1.28
Precedente Chiudi:
$1.28
Aprire:
$1.27
Volume 24 ore:
226.32K
Relative Volume:
0.44
Capitalizzazione di mercato:
$44.55M
Reddito:
$2.91M
Utile/perdita netta:
$-220.40M
Rapporto P/E:
-0.3516
EPS:
-3.64
Flusso di cassa netto:
$-176.15M
1 W Prestazione:
+0.79%
1M Prestazione:
+8.47%
6M Prestazione:
-24.26%
1 anno Prestazione:
-89.62%
Igm Biosciences Inc Stock (IGMS) Company Profile
Nome
Igm Biosciences Inc
Settore
Industria
Telefono
650-965-7873
Indirizzo
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Confronta IGMS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
IGMS
Igm Biosciences Inc
|
1.28 | 77.04M | 2.91M | -220.40M | -176.15M | -3.64 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-10 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
2025-01-10 | Downgrade | Guggenheim | Buy → Neutral |
2025-01-10 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2025-01-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2025-01-10 | Downgrade | Stifel | Buy → Hold |
2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
2024-10-01 | Downgrade | JP Morgan | Neutral → Underweight |
2024-10-01 | Downgrade | Truist | Buy → Hold |
2024-02-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
2023-12-15 | Downgrade | BofA Securities | Buy → Neutral |
2023-12-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
2022-11-09 | Ripresa | Jefferies | Buy |
2022-10-17 | Iniziato | JP Morgan | Neutral |
2022-08-29 | Iniziato | BofA Securities | Buy |
2021-12-13 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2021-11-05 | Aggiornamento | Wedbush | Neutral → Outperform |
2021-08-26 | Iniziato | Morgan Stanley | Overweight |
2021-01-29 | Iniziato | RBC Capital Mkts | Outperform |
2021-01-19 | Reiterato | H.C. Wainwright | Buy |
2020-12-22 | Downgrade | Wedbush | Outperform → Neutral |
2020-07-17 | Iniziato | Robert W. Baird | Outperform |
2020-07-01 | Iniziato | H.C. Wainwright | Buy |
2020-05-28 | Iniziato | SunTrust | Buy |
2020-04-22 | Iniziato | Wedbush | Outperform |
2019-10-14 | Iniziato | Guggenheim | Buy |
2019-10-14 | Iniziato | Jefferies | Buy |
2019-10-14 | Iniziato | Piper Jaffray | Overweight |
2019-10-14 | Iniziato | Stifel | Buy |
Mostra tutto
Igm Biosciences Inc Borsa (IGMS) Ultime notizie
Will IGM Biosciences Inc. stock benefit from interest rate changesHigh-profit stock alerts - jammulinksnews.com
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $5.50 Consensus Price Target from Brokerages - MarketBeat
What analysts say about IGM Biosciences Inc. stockStrong return on investment - Autocar Professional
IGM Biosciences Inc. Stock Analysis and ForecastHigh-performance investment picks - Autocar Professional
What drives IGM Biosciences Inc. stock priceExtraordinary profit generation - Autocar Professional
Is IGM Biosciences Inc. a good long term investmentRapidly growing investment returns - jammulinksnews.com
Stockholder Sues IGM Biosciences for Alleged SEC Violations - Bloomberg Law News
IGM Biosciences (NASDAQ:IGMS) Stock Price Down 5.9%Here's What Happened - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
Fierce Biotech Layoff Tracker 2025: Sail shrinks crew again; Sarepta lays off 500 staffers - Fierce Biotech
IGM Biosciences (NASDAQ:IGMS) Trading Down 5.9% – Here’s Why - Defense World
Why IGM Biosciences Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru
Concentra Group (CON) to Acquire IGM Biosciences - MSN
What makes IGM Biosciences Inc. stock price move sharplyFree Stock Market Real-Time Monitoring - Newser
How IGM Biosciences Inc. stock performs during market volatilityFree Access to Group - Newser
In Brief: Concentra Snaps Up Struggling IGM Biosciences In Latest Biotech Deal - insights.citeline.com
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: GMS, IGMS, MRC, and GRYP - The Malaysian Reserve
IGM Biosciences to be acquired by Concentra - The Pharma Letter
Regeneron bispecific approved for myeloma; Concentra to buy IGM - BioPharma Dive
Concentra to acquire IGM Biosciences for $1.247 per share plus CVR - Investing.com Nigeria
Concentra Biosciences, LLC agreed to acquire IGM Biosciences, Inc. for $76.3 million. - MarketScreener
IGM Biosciences Shares Surge on Takeover Agreement with Concentra - MSN
IGM Biosciences Gets Snapped Up In Concentra Deal - Finimize
IGM Biosciences stock soars after Concentra acquisition deal - Investing.com
IGM Biosciences Enters Definitive Merger Agreement with Concentra Biosciences for Acquisition - Nasdaq
IGM Biosciences stock soars after Concentra acquisition deal By Investing.com - Investing.com UK
IGM Biosciences, Inc.(NasdaqGS: IGMS) dropped from Russell 3000 Index - MarketScreener
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Consensus Recommendation of "Reduce" by Brokerages - MarketBeat
Igm biosciences CFO Tahir Misbah sells $1,825 in stock - Investing.com
Igm Biosciences Inc Azioni (IGMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):